NPC Research produces a newsletter several times a year featuring findings and insights relevant to our research, evaluation, technical assistance, and trainings. Additionally, we occasionally present job opportunities, news of our staff, and our volunteering in the community.
NPC News Vol. 5, Issue 1 (January 2018)
NPC News Vol. 4, Issue 4 (June 2017)
NPC News Vol. 4, Issue 3 (February 2017)
NPC News Vol. 4, Issue 2 (July 2016)
NPC News Vol. 4, Issue 1 (January 2016)
NPC News Vol. 3, Issue 4 (September 2015)
NPC News Vol. 3, Issue 3 (June 2015)
NPC News Vol. 3, Issue 2 (March 2015)
Chad Rodi, a Senior Research Associate with NPC Research, recently co-authored two articles published in the Child Welfare Journal. One is a descriptive study of the Children Affected by Methamphetamine (CAM) grant program, a federally funded effort to improve outcomes through the addition of targeted interventions for 1,940 families, including 2,596 adults and 4,245 children involved in 12 diverse Family Treatment Drug Courts (FTDCs) located across six U.S. states. The majority were children of parents with a primary methamphetamine use disorder. The other article is a descriptive study of the Children Affected by Methamphetamine (CAM) grant program, a federally funded effort to improve outcomes through the addition of targeted interventions for 1,940 families, including 2,596 adults and 4,245 children involved in 12 diverse Family Treatment Drug Courts (FTDCs) located across six U.S. states. The majority were children of parents with a primary methamphetamine use disorder. Learn more about the articles and Dr. Rodi.
Dr. Michael Finigan, Founder/Owner and Past President (retired) of NPC Research, was recognized as a “Science Giant” by the National Association of Drug Court Professionals (NADCP) on July 30, 2015, for his ground-breaking studies of drug court programs and for developing a group of research staff who have carried on this work. More than 5,000 attended the NADCP conference where he received his award. Dr. Finigan and his team have conducted hundreds of evaluations since his first detailed outcome and cost analyses of the Multnomah County STOP Drug Court in Portland in 1998. Dr. Finigan’s work included the development of a cost methodology, Transactional and Institutional Cost Analysis (TICA), and studies demonstrating that drug courts save the criminal justice system money by reducing re-offending. These studies have resulted in increased funding for drug courts nationally, at the local, state and federal levels. Dr. Finigan worked with a multi-disciplinary panel of drug court professionals, experts and researchers to develop national best practice standards for drug courts, based on the important work NPC has conducted.
Learn more about NPC’s drug court evaluation work.
In January 2015, Dr. Michael Finigan, company founder and former President, and his wife, Veronica Roth-Finigan, who was the company’s Vice President of Finance, retired after 25 years of service. NPC’s three Vice Presidents assumed leadership of the firm through a collaborative management model as Co-Presidents. Each has specific responsibilities in addition to sharing overall leadership and management.
Dr. Shannon M. Carey
Director of Development
Dr. Juliette R. Mackin
Director of Quality and Training
Jerod M. Tarte, M.A.
Director of Finance and Operations
Juliette Mackin, Jerod Tarte, and Shannon Carey
Along with the leadership transition at the start of 2015, the company began a transition to employee ownership. NPC will maintain the company focus on policy relevance and program improvement; dedication to high-quality services; cultural responsiveness; and family friendly, flexible, and caring workplace. These changes will reinforce employee engagement and commitment to our purpose and clients.
NPC, in collaboration with the Center for Court Innovation, recently completed a study in New York that examined the impact of the Rockefeller Drug Law Reform on judicial diversion. Our research found that the Rockefeller Drug Law Reform increased court-ordered treatment participation, reduced incarceration and recidivism among those treated, and increased taxpayer savings. The law, adopted in April 2009, eliminated mandatory prison sentences in New York State for most felony drug offenders and sought to link more felony-level drug and property offenders to treatment through judicial diversion. See the report and fact sheet.